# A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole

> **NCT00211393** · PHASE2 · COMPLETED · sponsor: **Manhattan Eye, Ear & Throat Hospital** · enrollment: 5 (actual)

## Conditions studied

- Chronic Central Serous Chorioretinopathy

## Interventions

- **DRUG:** ketoconazole

## Key facts

- **NCT ID:** NCT00211393
- **Lead sponsor:** Manhattan Eye, Ear & Throat Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2012-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211393, "A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00211393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*